Oscar Health (OSCR) Long-Term Investments (2020 - 2026)

Oscar Health has reported Long-Term Investments for 7 years, with the latest figure at $28.6 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 98.47% year-over-year to $28.6 million; the trailing twelve-month figure through Mar 2026 stood at $28.6 million (down 98.47% YoY), and the FY2025 full-year result was $1.5 billion, up 4663.87% from the prior year.
• Long-Term Investments for Q1 2026 stood at $28.6 million, down from $1.5 billion in the prior quarter.
• The five-year high for Long-Term Investments was $1.9 billion in Q1 2025, with the low at $27.3 million in Q1 2023.
• Historically, Long-Term Investments has averaged $597.3 million across 5 years, with a median of $222.9 million in 2022.
• Annual changes were most pronounced in 2025 — Long-Term Investments soared 6082.62% — and 2026, when it tumbled 98.47%.
• Oscar Health's Long-Term Investments stood at $222.9 million in 2022, then jumped by 373.33% to $1.1 billion in 2023, then slumped by 97.07% to $30.9 million in 2024, then jumped by 4663.87% to $1.5 billion in 2025, then tumbled by 98.05% to $28.6 million in 2026.
• The last three Long-Term Investments figures came in at $28.6 million (Q1 2026), $1.5 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.